Loading
Loading
BridgeBio Pharma ceo salary
Neil Kumar, Chief Executive Officer of BridgeBio Pharma, Inc. (BBIO), received $14,944,585 ($14.9M) in total compensation for FY2025, down 4.1% from the prior year. Stock awards of $10,606,275 were the largest component. Figures come from BridgeBio Pharma, Inc.'s DEF 14A filed 24 Apr 2026 (accession 0001140361-26-016723).
Reported total from the latest DEF 14A pay table. Source filing (accession 0001140361-26-016723). These figures come from BridgeBio Pharma, Inc.'s DEF 14A filed 24 Apr 2026 (accession 0001140361-26-016723).
| Component | Amount |
|---|---|
| Salary | $1,044,000 |
| Stock awards | $10,606,275 |
| Option awards | $1,874,992 |
| Other | $15,318 |
| Total | $14,944,585 |
FAQ
See also: BBIO ticker page